Traditional Chinese Plant Extract Targets Common Cellular Pathway to Treat Co-occurring Osteoporosis and Depression in Postmenopausal Women

Researchers identify a shared molecular pathway for osteoporosis and depression in postmenopausal women, treatable with a single traditional plant extract.

By: AXL Media

Published: Apr 27, 2026, 7:08 AM EDT

Source: Information for this report was sourced from Science and Technology Review Publishing House

The Biological Intersection of Bone Loss and Mental Health

Postmenopausal women frequently face a debilitating combination of osteoporosis and depression, two conditions that modern medicine has traditionally treated as separate clinical entities. However, emerging research suggests that these health challenges are deeply intertwined through the systemic effects of estrogen loss. The decline in estrogen levels triggers an increase in oxidative stress and impairs the mitochondria, the energy-producing powerhouses of the cell. This cellular degradation simultaneously weakens bone-forming cells and disrupts the brain’s mood-regulating regions, creating a biological environment where skeletal and neurological health fail in tandem.

Limitations of Conventional Multi-Drug Therapies

Current treatment protocols for postmenopausal health often require a complex cocktail of drugs that fail to address the underlying shared mechanisms of disease. While osteoporosis medications can fortify bone structures, they offer no psychiatric benefit, and standard antidepressants do not prevent the loss of bone mineral density. Hormone replacement therapy (HRT) can address both issues but carries long-term risks for cardiovascular disease and certain cancers, leaving many women without a safe, comprehensive option. This therapeutic gap has led scientists to seek out natural compounds that can target the common molecular pathways linking the skeleton and the brain.

Evaluating Drynaria Fortunei in Comorbidity Models

A collaborative research team from the China Academy of Chinese Medical Sciences and several major universities recently investigated the therapeutic potential of total flavonoids from Drynaria fortunei (TFDF). This plant extract has long been a staple in traditional Chinese medicine for its purported bone-strengthening properties. For this study, researchers developed a unique animal model that mimicked both postmenopausal state and chronic stress. This allowed for the simultaneous assessment of skeletal deterioration and behavioral changes, providing a more accurate framework for how these conditions manifest together in human patients.